Facetten
Zugriff
Einrichtung
Medientyp
- Text 7
Karte
Erscheinungsjahr
Autor/in
- Thaci, D
- Mrowietz, U 5
- Reich, K 5
- Augustin, M 3
- Radtke, M A 2
- alle zeigen
Sprache
7 Einträge gefunden
-
Five-year efficacy and safety of tildrakizumab in patients with moderate-to-severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2)
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
Continued treatment with secukinumab is associated with high retention or regain of response
2020 - Forschungsinformationssystem des UKE -
Topology of psoriasis in routine care: results from high-resolution analysis of 2009 patients
2019 - Forschungsinformationssystem des UKE -
Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practice
2019 - Forschungsinformationssystem des UKE -
Mehr Sicherheit für unsere Patienten. Aktuelle Ergebnisse der Pharmakovigilanz in PsoBest
- Radtke, Marc Alexander
- Spehr, Christina
- Rustenbach, Stephan Jeff
- Mrowietz, U
- Thaci, D
- Reich, K
- Augustin, Matthias
-
Drug safety of systemic treatments for psoriasis: Results from The German Psoriasis Registry PsoBest
2015 - Forschungsinformationssystem des UKE